In breast cancer, S100A4 drives the nuclear localization of EGR1 by promoting the binding of EGR1 to importin 7, and EGR1 next enhances tumor invasion and metastasis by downregulating β-catenin through the PTEN–AKT–GSK3β signal transduction (44). Here, PTEN is linked to neoplasm.